On April 24, 2025, Lexaria Bioscience Corp. entered into an agreement to sell 1,925,000 shares of common stock at $1.00 each and pre-funded warrants for $0.9999 each, raising $2 million in total gross proceeds. The funds will be used for working capital purposes, with the offering closing on April 28, 2025.